ELISA: 1/1,000. Western blotting: 1/100 - 1/500. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
PBS with 0.09 % (W/V) sodium azide
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Target
LRPAP1
(Low Density Lipoprotein Receptor-Related Protein Associated Protein 1 (LRPAP1))
wu:fi20f07 antikoerper, wu:fi22c06 antikoerper, LRPAP1 antikoerper, DKFZp459I2430 antikoerper, A2MRAP antikoerper, A2RAP antikoerper, HBP44 antikoerper, MRAP antikoerper, RAP antikoerper, AA617339 antikoerper, AI790446 antikoerper, AU042172 antikoerper, C77774 antikoerper, alpha-2-macroglobulin receptor-associated protein-like antikoerper, low density lipoprotein receptor-related protein associated protein 1 antikoerper, LDL receptor related protein associated protein 1 antikoerper, LDL receptor related protein associated protein 1 L homeolog antikoerper, LOC100231803 antikoerper, lrpap1 antikoerper, LRPAP1 antikoerper, Lrpap1 antikoerper, lrpap1.L antikoerper
Hintergrund
LRPAP1 interacts with LRP1/alpha-2-macroglobulin receptor and glycoprotein 330.Synonyms: Alpha-2-MRAP, Alpha-2-macroglobulin receptor-associated protein, Low density lipoprotein receptor-related protein-associated protein 1, RAP